SOUTH AFRICA
More than 40 pharmaceutical companies, including the world's largest and most powerful ones, will file a lawsuit against the South African government in a bid to stop it from passing a legislation aimed at reducing the price of medicines. The companies had tried to stop the South African parliament from passing the Medicines and Related Substances Act of 1997, but after failing to do so the industry decided to file the lawsuit, thereby preventing the act from coming into force. The act not only seeks to regulate the marketing and distribution of medicines in South Africa but also aims at encouraging the import of cheaper drugs and generic substitutes. Drugs used in the treatment of Acquired Immuno Deficiency Syndrome (aids) are too expensive
Related Content
- Learning Interrupted: Global Snapshot of Climate-Related School Disruptions in 2024
- Africa Solar Outlook 2025
- Blue and Green Drop Project Report 2024
- Global LNG outlook 2024-2028
- Empowering women for effective climate change adaptation: the role of the private sector
- Blackouts and backsliding: energy subsidies in South Africa 2023